Browsing by Author "Herrera, Pablo"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- ItemA DPG method for the quad-curl problem(2023) Fuhrer, Thomas; Herrera, Pablo; Heuer, NorbertWe derive an ultraweak variational formulation of the quad-curl problem in two and three dimensions. We present a discontinuous Petrov-Galerkin (DPG) method for its approximation and prove its quasi-optimal convergence. We illustrate how this method can be applied to the Stokes problem in two dimensions, after an application of the curl operator to eliminate the pressure variable. In this way, DPG techniques known from Kirchhoff-Love plates can be used. We present an a priori error estimate that improves a previous approximation result for effective shear forces by using a less restrictive regularity assumption. Numerical experiments illustrate our findings.
- ItemTechnology-Assisted Collaborative Care Program for People with Diabetes and/or High Blood Pressure Attending Primary Health Care: A Feasibility Study(2021) Martinez, Pablo; Guajardo, Viviana; Gomez, Victor E.; Brandt, Sebastian; Szabo, Wilsa; Soto-Brandt, Gonzalo; Farhang, Maryam; Baeza, Paulina; Campos, Solange; Herrera, Pablo; Rojas, GracielaThe comorbidity of depression with physical chronic diseases is usually not considered in clinical guidelines. This study evaluated the feasibility of a technology-assisted collaborative care (TCC) program for depression in people with diabetes and/or high blood pressure (DM/HBP) attending a primary health care (PHC) facility in Santiago, Chile. Twenty people diagnosed with DM/HBP having a Patient Health Questionnaire-9 score & GE; 15 points were recruited. The TCC program consisted of a face-to-face, computer-assisted psychosocial intervention (CPI, five biweekly sessions), telephone monitoring (TM), and a mobile phone application for behavioral activation (CONEMO). Assessments of depressive symptoms and other health-related outcomes were made. Thirteen patients completed the CAPI, 12 received TM, and none tried CONEMO. The TCC program was potentially efficacious in treating depression, with two-thirds of participants achieving response to depression treatment 12 weeks after baseline. Decreases were observed in depressive symptoms and healthcare visits and increases in mental health-related quality of life and adherence to treatment. Patients perceived the CPI as acceptable. The TCC program was partially feasible and potentially efficacious for managing depression in people with DM/HBP. These data are valuable inputs for a future randomized clinical trial.